Both chronic kidney disease (CKD) and atrial fibrillation are increasingly common conditions. Recent estimates suggest that 6% to 8% of noninstitutionalized US adults have an estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2 (indicating CKD stage 3 or worse) and nearly 10% have albuminuria.1 Similarly, atrial fibrillation is estimated to have affected more than 2.7 million Americans in 2010.2 The prevalence and incidence of atrial fibrillation increases with the severity of CKD and, conversely, patients with atrial fibrillation are more likely to have CKD or develop progressive kidney dysfunction. It would therefore seem that aggressive treatment of atrial fibrillation, particularly with regard to oral anticoagulation for stroke prevention, would be paramount in patients with CKD.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have a Hemorrhagic Stroke?
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.